cemiplimab
Showing 51 - 66 of 66
Advanced Malignancies Trial in Japan (Cemiplimab, Ipilimumab, Platinum-doublet chemo)
Recruiting
- Advanced Malignancies
- Cemiplimab
- +2 more
-
Nagoya, Aichi, Japan
- +20 more
Jan 7, 2022
Hodgkin Lymphoma Trial (Cemiplimab, Involved-site radiotherapy (IS-RT))
Withdrawn
- Hodgkin Lymphoma
- Cemiplimab
- Involved-site radiotherapy (IS-RT)
- (no location specified)
Jan 13, 2021
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)
Recruiting
- Non-Small Cell Lung Cancer
- BNT116
- +2 more
-
Baltimore, Maryland
- +14 more
Dec 19, 2022
Advanced Malignant Skin Tumor, Metastatic Malignant Skin Tumor Trial in Los Angeles (drug, biological, other)
Recruiting
- Advanced Malignant Skin Neoplasm
- Metastatic Malignant Skin Neoplasm
- Atezolizumab
- +7 more
-
Los Angeles, California
- +1 more
Apr 1, 2021
HER2 Positive Solid Tumors Trial in Australia, Korea, Republic of, United States (SBT6050, pembrolizumab, Cemiplimab)
Active, not recruiting
- HER2 Positive Solid Tumors
- SBT6050
- +2 more
-
Boston, Massachusetts
- +11 more
Jun 27, 2022
Advanced Cutaneous Squamous Cell Carcinoma Trial in Worldwide (cemiplimab)
Active, not recruiting
- Advanced Cutaneous Squamous Cell Carcinoma
- cemiplimab
-
Phoenix, Arizona
- +77 more
Jan 4, 2023
Cutaneous Squamous Cell Carcinoma Trial in Worldwide (Cemiplimab, Placebo)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Cemiplimab
- Placebo
-
Gilbert, Arizona
- +143 more
Dec 1, 2022
Carcinoma,Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma Trial in Worldwide (Pemetrexed,
Active, not recruiting
- Carcinoma，Non-Small-Cell Lung
- +3 more
- Pemetrexed
- +5 more
-
Albury, New South Wales, Australia
- +192 more
Sep 19, 2022
NSCLC Trial in United States (REGN4659, Cemiplimab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- REGN4659
- Cemiplimab
-
Chicago, Illinois
- +5 more
Mar 11, 2020
Squamous Cell Carcinoma (SCC), Recurrent or Metastatic, Platinum-refractory Cervical Cancer Trial in Worldwide (Cemiplimab,
Active, not recruiting
- Squamous Cell Carcinoma (SCC)
- Recurrent or Metastatic, Platinum-refractory Cervical Cancer
- Cemiplimab
- Investigator Choice (IC) Chemotherapy
-
Phoenix, Arizona
- +104 more
Mar 11, 2022
Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)
Active, not recruiting
- Carcinoma, Basal Cell
- cemiplimab
-
Phoenix, Arizona
- +70 more
Jun 30, 2022
Cutaneous Squamous Cell Carcinoma Trial (cemiplimab)
No longer available
- Cutaneous Squamous Cell Carcinoma
- cemiplimab
- (no location specified)
Jul 30, 2019
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020